Consistent with this, CTLA-4 overexpression on tumor-infiltrating lymphocytes has been considered as a red flag for melanoma patients [hazard ratio (HR): 7.962, 95% CI: 1.832–34.598, P-value = 0.006] (75). Here, CTLA4 is linked to neoplasm.